Unifirst Announces Financial Results for the Third Quarter of Fiscal 2024
WILMINGTON, Mass., June 26, 2024 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results […]
iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024
NASHUA, N.H., June 26, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer […]
TSX News -
Century Announces Filing of March 31, 2024 Year End Financial Results, Management Discussion and Analysis and Annual Information Form
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION INTHE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, June 26, 2024 […]
Ocean Power Technologies Reaches Agreement in Principle for Delivery of Multiple Unmanned Surface Vehicles to US Government
MONROE TOWNSHIP, N.J., June 26, 2024 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), […]
Layoffs Hit 50% of Finance Companies Surveyed; Also Facing Shortages in Fintech and AI Expertise
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) — To help executives understand, react, and adapt to the ongoing challenges within […]
AYR Cannabis Dispensary Strengthens Illinois Retail Presence With Opening Of Hometown Dispensary
MIAMI, June 26, 2024 (GLOBE NEWSWIRE) — AYR Cannabis Dispensary, a cannabis retail chain owned by AYR Wellness Inc. (CSE: […]
BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF […]
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
MALVERN, Pa., June 26, 2024 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), […]
TSX News -
Medicenna Announces EMA Approval of its Clinical Trial Application to Expand its Phase 1/2 ABILITY-1 Study to Europe
– ABILITY-1 study is currently enrolling patients for the treatment of advanced solid tumors with MDNA11, a novel long-acting IL-2 […]
TSX News -
Kneat and Körber Pharma Consulting Partner to Accelerate Life Sciences Digitalization
LIMERICK, Ireland, June 26, 2024 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (OTC: KSIOF), a leader in digitizing and automating […]
